TOH edition: Monday, 5 October 2026 · Health & Medicine
Could a pill stop Ebola after exposure? More than 250 people in Congo join a trial to find out
Reported by nwaonline.com
Publisher date:
More than 250 people in Congo have enrolled in a trial testing whether an experimental antiviral pill can prevent Ebola from developing after exposure. Participants include health workers and patients’ relatives, but the drug’s effectiveness against the outbreak’s Bundibugyo virus has not yet been established.
The trial could open a way to protect exposed people against a virus with no approved vaccine or treatment, although protection remains unproven.
Read the original report at nwaonline.com (opens in a new tab) →
Read the full front page of Monday, 5 October 2026 →
Get tomorrow's front page
Five reasons to believe in progress, delivered once a day.